Cargando…
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
Localized prostate cancer (PCa) is a clinically heterogeneous disease, which presents with variability in patient outcomes within the same risk stratification (low, intermediate or high) and even within the same Gleason scores. Genomic tools have been developed with the purpose of stratifying patien...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820857/ https://www.ncbi.nlm.nih.gov/pubmed/27044421 http://dx.doi.org/10.1186/s12916-016-0613-7 |